ZPD A

ZPD A/S is a Danish biotechnology company specializing in the production of high-quality Chondroitin Sulfate for the global pharmaceutical and nutraceutical industries. Founded in 1994, the company operates a state-of-the-art manufacturing facility in Esbjerg, Denmark, which is GMP-certified for the production of Active Pharmaceutical Ingredients (APIs). ZPD is unique in its ability to provide full traceability, leveraging a secure supply chain of bovine raw materials sourced primarily from its former partner, Danish Crown. The company's products are used extensively in treatments for osteoarthritis and joint health, meeting the rigorous standards of the European and Japanese Pharmacopoeias. In 2020, ZPD became a wholly-owned subsidiary of the Japanese firm Zeria Pharmaceutical, further strengthening its position in the global market. The company continues to focus on innovation in extraction and purification technologies to ensure the highest purity and safety of its biological ingredients.